APOLLO ENDOSURGERY INC (APEN)

US03767D1081 - Common Stock

10  +0.08 (+0.81%)

After market: 9.99 -0.01 (-0.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
42.05M
-17.08%
62.989M
49.80%
76.856M
22.01%
91.023M
18.43%
111.2M
22.17%
184.47M
65.89%
EBITDA
YoY % growth
-12.06M
51.88%
-15.967M
-32.40%
-24.856M
-55.67%
-17.33M
30.28%
-13.182M
23.94%
N/A
EBIT
YoY % growth
-15.79M
45.78%
-19.199M
-21.59%
-27.822M
-44.91%
-29.618M
-6.46%
-26.049M
12.05%
-27.671M
-6.22%
Operating Margin
-37.55%-30.48%-36.20%-32.54%-23.43%-15.00%
EPS
YoY % growth
-1.04
31.58%
-0.89
14.42%
-0.98
-9.99%
-0.85
13.10%
-0.73
13.67%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.22
-5.24%
-0.22
16.31%
-0.20
28.36%
-0.19
15.35%
-0.19
12.31%
-0.18
15.62%
-0.14
28.81%
-0.13
31.58%
Revenue
Q2Q % growth
20.25M
21.53%
22.921M
18.72%
23.452M
19.82%
24.527M
15.07%
23.964M
18.34%
26.406M
15.20%
27.393M
16.80%
29.342M
19.63%
EBITDA
Q2Q % growth
-5.14M
21.00%
-4.923M
3.47%
-4.389M
-8.54%
-4.318M
8.91%
-5.145M
-0.10%
-4.378M
11.07%
-2.857M
34.91%
-2.175M
49.63%
EBIT
Q2Q % growth
-7.806M
-7.72%
-7.612M
-15.72%
-7.138M
-13.46%
-6.781M
12.00%
-7.692M
1.47%
-7.024M
7.73%
-5.506M
22.86%
-4.871M
28.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
-0.23
15.21%
-0.21-0.02-7.91%
Q3 2022
Q2Q % growth
-0.28
-21.74%
-0.24-0.04-18.32%
Q2 2022
Q2Q % growth
-0.26
-18.18%
-0.23-0.03-13.29%
Q1 2022
Q2Q % growth
-0.21
-23.53%
-0.20-0.01-4.68%
Q4 2021
Q2Q % growth
-0.27
-92.86%
-0.20-0.07-38.11%
Q3 2021
Q2Q % growth
-0.23
-109.09%
-0.290.0619.47%
Q2 2021
Q2Q % growth
-0.22
26.67%
-0.20-0.02-9.67%
Q1 2021
Q2Q % growth
-0.17
65.31%
-0.220.0524.24%
Q4 2020
Q2Q % growth
-0.14
58.82%
-0.260.1246.17%
Q3 2020
Q2Q % growth
-0.11
72.50%
-0.210.1048.65%
Q2 2020
Q2Q % growth
-0.30
25.00%
-0.340.0410.87%
Q1 2020
Q2Q % growth
-0.49
-28.95%
-0.500.011.96%
Q4 2019
Q2Q % growth
-0.34
29.17%
-0.390.0512.28%
Q3 2019
Q2Q % growth
-0.40
11.11%
-0.430.036.63%
Q2 2019
Q2Q % growth
-0.40
24.53%
-0.39-0.01-3.20%
Q1 2019
Q2Q % growth
-0.38
19.15%
-0.37-0.01-2.07%
Q4 2018
Q2Q % growth
-0.48 -0.37-0.11-28.34%
Q3 2018
Q2Q % growth
-0.45 -0.36-0.09-25.16%
Q2 2018
Q2Q % growth
-0.53 -0.45-0.08-17.43%
Q1 2018
Q2Q % growth
-0.47 -0.41-0.06-15.20%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
21.314M
31.80%
20.278M1.036M5.11%
Q3 2022
Q2Q % growth
19.573M
19.71%
18.51M1.063M5.74%
Q2 2022
Q2Q % growth
19.307M
16.24%
18.644M663K3.56%
Q1 2022
Q2Q % growth
16.662M
20.22%
16.13M532K3.30%
Q4 2021
Q2Q % growth
16.171M
25.75%
16.57M-399K-2.41%
Q3 2021
Q2Q % growth
16.351M
27.44%
15.707M644K4.10%
Q2 2021
Q2Q % growth
16.61M
194.50%
13.948M2.662M19.09%
Q1 2021
Q2Q % growth
13.86M
29.29%
11.943M1.917M16.05%
Q4 2020
Q2Q % growth
12.86M
7.26%
11.23M1.63M14.51%
Q3 2020
Q2Q % growth
12.83M
13.94%
10.177M2.653M26.07%
Q2 2020
Q2Q % growth
5.64M
-60.42%
5.292M348K6.58%
Q1 2020
Q2Q % growth
10.72M
-18.85%
8.908M1.812M20.34%
Q4 2019
Q2Q % growth
11.99M
-21.01%
12.698M-708K-5.58%
Q3 2019
Q2Q % growth
11.26M
-20.37%
12.991M-1.731M-13.32%
Q2 2019
Q2Q % growth
14.25M
-9.75%
13.842M408K2.95%
Q1 2019
Q2Q % growth
13.21M
-16.07%
13.472M-262K-1.94%
Q4 2018
Q2Q % growth
15.18M 15.263M-83K-0.54%
Q3 2018
Q2Q % growth
14.14M 16.545M-2.405M-14.54%
Q2 2018
Q2Q % growth
15.79M 16.974M-1.184M-6.98%
Q1 2018
Q2Q % growth
15.74M 16.337M-597K-3.65%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%